This market research report on IV (Intravenous) Solution is analyzed by Type and Nutrients for each of the geographic regions-North America, Europe, Asia-Pacific and Rest of World. The global IV Solutions market segments includes by Type- Partial Parenteral Nutrition (PPN) & Total Parenteral Nutrition (TPN); by Nutrients-Carbohydrates, Salt and Electrolytes, Minerals and Vitamins and Amino Acids. Estimates and projections for the total global IV solutions market are given by geographic regions. Business profiles of 14 major companies are discussed in the research report. The research report covers 218 companies that are engaged in IV Solutions and related products. Major Contract Research Organizations serving IV Solution market are also covered in the Corporate Directory section of this market research report. Information related to product developments, partnerships, collaborations, and mergers and acquisitions is also included in the report. A total of 202 exhibits complements the market research report.

Free Sample Research Report

Download Table of contents

Intravenous feeding is the short-term administration of supplementary nutrients through a solution that is introduced into the vein. Peripheral intravenous feeding refers to infusion of the fluid in a small vein on the surface of an arm, leg or the scalp. On the other hand, central venous feeding refers to infusion into a large vein which is embedded deep within a body. Only limited quantities of nutrients can be administered through peripheral intravenous feeding as there is the danger of incurring phlebitis and/or clots (thrombi) if concentrated solutions are used. However, in central venous feeding it is possible to infuse concentration nutrient solutions as the rapid blood flow in the central veins can promptly dilute the solution thereby minimizing the possibility of causing irritation to the vein.

Global Intravenous Solutions market is projected to grow at 13.5% compounded annually from 2005 through 2013. The United States, the leading market (44.3% of global market share in 2006) for Intravenous Solutions presently is projected to manage the leading position throughout the analysis period with its share dropping to 43% by 2013. Due to the cost advantage and rapid increase in population, Asia-Pacific is the fastest growing (14.25% during 2005-2013) market for Intravenous Solutions. Asia-Pacific and Rest of World are expected to gain in market shares.

The alterations in Government reimbursement policies have motivated hospitals to explore more effective methods of administering drugs through the intravenous route. The changes in Government policies have also facilitated the development of light and portable injection devices. These are handy as patients can now receive intravenous treatments in doctor’s clinics or even in their own homes. It is estimated that $2 billion is spent on intravenous solutions annually, of which almost 90% is used by hospitals. There is a sharp rise in the demand for portable intravenous devices that allow patients to move about while wearing them. The need for such devices has doubled annually for the last four years.

Ajinomoto Co., Inc. (Japan)
B. Braun Melsungen AG (Germany)
Baxter (India) Pvt. Ltd. (India)
Baxter International (USA)
Claris Lifesciences Ltd. (India)
Fresenius Kabi (Germany)
Gulf Inject LLC (UAE)
Groupe Danone (France)
Hospira, Inc (USA)
Kelun Pharmaceutical Co., Ltd. (China)
Kyowa Hakko Kogyo Co., Ltd. (Japan)
Laboratorios Grifols (Spain)
Liqvor Pharmaceuticals (Armenia)
Marck Biosciences Ltd. (India)
Nestle SA (Switzerland)
Otsuka Pharmaceutical Co., Ltd. (Japan)
Sino-Swed Pharmaceutical Corp., Ltd. (China)
Terumo Corporation (Japan)

For those who are intrested to buy the report by chapter:

CHAPTER	TITLE	SHORT DESCRIPTION	PRICE (US$)
I	Scope and Methodology	This chapter provides information regarding the research methodology, limitations of the study, market measuring units and exchange rates used. * Will be delivered free with purchase of any of the other chapters mentioned below.	FREE*
II	Report Synopsis	Synopsis of the report summarizes the global Intravenous Solutions market by Type and Nutrient. Global market is also analyzed by geographic regions including North America, Europe, Asia-Pacific and Rest of World. The chapter provides market values in US$ (2005-2012) for each geographic region including the US, Canada, UK, Germany, France, Switzerland, Finland, Russia, Japan, China, India, and Australia. A List of major companies is also provided.	$1150
III	Product / Technology Research	This chapter gives an insight into Intravenous Solutions market through definitions, segmentation and applications. The chapter also provides market values in US$ (for the period 2005 through 2012). The chapter also includes product trends and potential opportunities.	$800
IV	Market Dynamics	Market Dynamics chapter provides information on global markets for Intravenous Solutions. The chapter includes global market analysis (in US$) by geographic region; analysis of each region by both Type and Nutrient; a brief business profile of major global companies; and a report of corporate activities such as mergers and acquisitions, partnerships, new product developments/launches, etc. The section includes key market trends and an industry outlook.	$1850
V	Corporate Directory	This chapter provides a global region-wise list of 45 companies, CROs and academic institutions that offer Intravenous Solutions products and/or services.	$300